Medical specialists from France tagged as investigators in clinical trials studying Neuroblastoma

Total 36 results

Anne EL AATMANI, Pharm, PhD
Seen in:
- Strasbourg, Service de Pharmacie - Stérilisation - CHU de Strasbourg - France
Trials:
- NCT06275334 (Principal Investigator)
Conditions:
- Neuroblastoma
Anne-Sophie Defachelles, Dr
Seen in:
- Lille, Centre Oscar Lambret
Trials:
- NCT04253015 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Antoine Gourmel, MD
Seen in:
- Amiens, CHU Amiens
- Somme, Amiens, CHU AMIENS-PICARDIE - Hôpital Nord
Trials:
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Arnaud PETIT, MD
Seen in:
- Paris, Hôpital Armand Trousseau
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Aude MARIE CARDINE, MD
Seen in:
- Rouen, Hopital Charles Nicolle
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Benoît DUMONT, MD
Seen in:
- Lyon, Centre Leon Bérard
- Lyon, LYON Centre Léon Bérard
Trials:
- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Birgit Geoerger
Seen in:
- Villejuif Cedex, Gustave Roussy
Trials:
- NCT04238819 (Principal Investigator)
- NCT03899792 (Principal Investigator)
Conditions:
Carole Coze, Dr
Seen in:
- Marseille, Hopital d'Enfants de la Timone
- Marseille, Hopital d'Enfants la Timone
- Marseille, Hôpital de la Timone, Hôpital des Enfants
- Marseille, Marseille Chu
Trials:
- NCT04253015 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Cécile PERRET, MD
Seen in:
- Grenoble, CHU Grenoble
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Chrystelle DUPRAZ, MD
Seen in:
- Poitiers, Hopital jean Bernard
- Poitiers, University Hospital of Poitiers
Trials:
- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
Conditions:
Claire BERGER, MD
Seen in:
- Saint-Étienne, CHU de Saint-Etienne - Hopital Nord
- Saint-Étienne, Hopital Nord
Trials:
- NCT05476939 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Claire Briandet, MD
Seen in:
- Côte d'Or, Dijon, CHU Dijon - Hôpital des Enfants
- Dijon, CHU Bocage
- Dijon, CHU Francois Mitterrand
- Dijon, DIJON CHU Hopital François Mitterand
- Dijon, DIJON Hôpital d'enfants
- Strasbourg, Service de Pédiatrie 3
Trials:
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
- NCT03690570 (Principal Investigator)
Conditions:
Claire Pluchart, MD
Seen in:
- Marne, Reims, CHU REIMS - American Memorial Hospital
- Reims, CHU Reims
- Reims, Chur de Reims
- Reims, Reims Chu
- Reims, University Hospital of Reims
Trials:
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Claudia PASQUALINI, MD
Seen in:
- Villejuif, Gustave Roussy
- Villejuif, Institut Gustave Roussy
Trials:
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
Conditions:
Damien BODET, MD
Seen in:
- Caen, CHU CAEN - Fédération de cancérologie - niveau 21
- Caen, CHU Caen
- Caen, Caen CHU
Trials:
- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Dominique Valteau-Couanet, Dr
Seen in:
- Villejuif, Institut Gustave Roussy
Trials:
- NCT04253015 (Principal Investigator)
Conditions:
- Neuroblastoma
Emilie BERTHON, PhamD, PhD
Seen in:
- Strasbourg, Service de Pharmacie - Stérilisation - CHU de Strasbourg - France
Trials:
- NCT06275334 (Principal Investigator)
Conditions:
- Neuroblastoma
Estelle THEBAUD, MD
Seen in:
- Nantes, CHU Nantes
- Nantes, Chr Nantes
Trials:
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Gudrun SCHLEIERMACHER, MD
Seen in:
- Paris, Institut Curie
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Isabelle AERTS
Seen in:
- Paris, Institut Curie
Trials:
- NCT04238819 (Principal Investigator)
Conditions:
- Relapsed Solid Tumor;
- Refractory Solid Tumor
Joy BENADIBA, MD
Seen in:
- Nice, CHU Nice
- Nice, CHU de NICE - Hôpital Archet 2
Trials:
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
Conditions:
Julie TANDONNET, MD
Seen in:
- Bordeaux, Hopital des Enfants
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Julien LEJEUNE, MD
Seen in:
- Tours, Hôpital Clocheville
- Tours, University Hospital of Tours
Trials:
- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
Conditions:
Justyna Kanold, MD
Seen in:
- Clermont-Ferrand, CHU D'Estaing de CLERMONT FERRAND
- Clermont-Ferrand, CHU ESTAING Centre Régional de Cancérologie et Therapie Cellulaire Pediatrique (CRCTCP)
- Puy-de-Dôme, Clermont-Ferrand, CHU Clermont- Ferrand - Hôpital Estaing
Trials:
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Liana CARAUSU, MD
Seen in:
- Brest, CHRU Brest
- Brest, CHRU de Brest - Hôpital Morvan
- Brest, Chu de Brest Morvan
Trials:
- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Ludovic MANSUY, MD
Seen in:
- Vandoeuvre Les Nancy, CHU Nancy
- Vandoeuvre Les Nancy, Nancy CHU
- Vandœuvre-lès-Nancy, CHRU NANCY - Hôpital d'Enfants
- Vandœuvre-lès-Nancy, CHU NANCY- Hôpital d'Enfants
Trials:
- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Marion GAMBART, MD
Seen in:
- Toulouse, Hopital des Enfants
Trials:
- NCT05192980 (Principal Investigator)
Conditions:
Pierre LEBLOND
Seen in:
- Rhône-Alpes, Lyon, Centre Leon Bérard
Trials:
- NCT04238819 (Principal Investigator)
Conditions:
- Relapsed Solid Tumor;
- Refractory Solid Tumor

Clinical Trials on Neuroblastoma

Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 Neuroblastoma

United States, Canada, Australia, New Zealand
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of DNA in Blood Samples From Patients With Neuroblastoma

Recurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Recurrent Neuroblastoma | Stage 4S Neuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Active, not recruiting

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States, Puerto Rico, Canada, Australia, New Zealand, Netherlands, Saudi Arabia, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Specimens From Young Patients With Neuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4 Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma

Recurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Stage 4S Neuroblastoma

United States

Medical specialists from France tagged as investigators in clinical trials studying Neuroblastoma

Clinical Trials on Neuroblastoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations